Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Ultracet Combo Product Labeling Cites Faster Pain Action Than Ultram

Executive Summary

Johnson & Johnson's Ultracet delivers a faster onset of action than Ultram (tramadol) alone, labeling for the combination tramadol/acetaminophen drug notes.

You may also be interested in...



Ultram Pain Indication Cannot Be Divided, J&J Says In Response To Teva

The indication for Ultram (tramadol) cannot be divided into chronic versus acute pain to justify omission of patent-protected titration dosing from generic labeling, Johnson & Johnson told FDA

Ultram Pain Indication Cannot Be Divided, J&J Says In Response To Teva

The indication for Ultram (tramadol) cannot be divided into chronic versus acute pain to justify omission of patent-protected titration dosing from generic labeling, Johnson & Johnson told FDA

J&J Ultram Titration Relabeling Should Not Block Generics, Apotex Argues

Apotex' citizen petition requesting approval of generic Ultram argues that Johnson & Johnson did not make labeling changes for safety or efficacy reasons

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel